Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison M Friedmann

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2021
Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node RadiationMonika L Metzger, Michael P Link, Amy L Billett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2021
Favorable Trisomies and <i>ETV6-RUNX1</i> Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331Leonard A Mattano, Meenakshi Devidas, Kelly W Maloney, et al.
Cancers|February 13, 2026
Characterization of Clinical Outcomes for Patients with Relapsed High-Risk Neuroblastoma After Autologous Stem Cell Transplant and External Beam RadiotherapyMathew Lin, Jie Jane Chen, Rochelle Bagatell, et al.
The Oncologist|April 27, 2021
Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell SarcomaLucas R Massoth, Yin P Hung, Judith A Ferry, et al.
Blood|January 13, 2026
Dose-dense chemotherapy enables elimination of RT for majority of low-risk pediatric Hodgkin lymphoma: PHC study HOD08Jamie E Flerlage, Angela M Feraco, Yiwang Zhou, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 16, 2024
Patterns of recurrence after radiotherapy for high-risk neuroblastoma: Implications for radiation dose and fieldKevin X Liu, Sherif G Shaaban, Jie Jane Chen, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2021
Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node RadiationMonika L Metzger, Michael P Link, Amy L Billett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2021
Favorable Trisomies and <i>ETV6-RUNX1</i> Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331Leonard A Mattano, Meenakshi Devidas, Kelly W Maloney, et al.
Cancers|February 13, 2026
Characterization of Clinical Outcomes for Patients with Relapsed High-Risk Neuroblastoma After Autologous Stem Cell Transplant and External Beam RadiotherapyMathew Lin, Jie Jane Chen, Rochelle Bagatell, et al.
The Oncologist|April 27, 2021
Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell SarcomaLucas R Massoth, Yin P Hung, Judith A Ferry, et al.
Blood|January 13, 2026
Dose-dense chemotherapy enables elimination of RT for majority of low-risk pediatric Hodgkin lymphoma: PHC study HOD08Jamie E Flerlage, Angela M Feraco, Yiwang Zhou, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 16, 2024
Patterns of recurrence after radiotherapy for high-risk neuroblastoma: Implications for radiation dose and fieldKevin X Liu, Sherif G Shaaban, Jie Jane Chen, et al.
Pageof 5